- Galera Therapeutics (NASDAQ:GRTX) appointed Mark J. Bachleda, Pharm.D., M.B.A., as Chief Commercial Officer and Jennifer Evans Stacey, Esq., as Chief Legal and Compliance Officer and Secretary.
- Both executives join Galera with 25+ years of leadership experience within the biopharma industry.
- Prior to joining Galera, Mark served as VP & U.S. Business Unit Head for Bristol Myers Squibb’s CAR T cell therapy franchise; Jennifer was most recently VP, General Counsel, Secretary and Government Relations at The Wistar Institute, an independent international biomedical research institution.